Stephen Kanes insider trades

Open-market stock purchases and sales by Stephen Kanes, Chief Medical Officer at Centessa Pharmaceuticals plc, from SEC Form 4 filings since Jul 23, 2014.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -52%.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$8.4M
Feb 2, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—

Companies traded

  • CNTA Centessa Pharmaceuticals plc: other filings, last Jun 24, 2026
  • SAGE Sage Therapeutics, Inc: 1 buy, 24 sales, last Oct 19, 2021

Get free alerts when Stephen Kanes files a new trade →